Related Experiment Video
Updated: Jul 16, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Malignancy Recorded Among Secondary Diagnoses and In-Hospital Mortality in Patients Hospitalized with Chronic Ulcers:
Mona Taroi Yassin Cataniciu1, Ilie Gligorea2, Liliana Vecerzan Novac1
1Faculty of Medicine, Lucian Blaga University of Sibiu, 550169 Sibiu, Romania.
Abstract:
Background/Objectives: Chronic ulcers are common among older and multimorbid hospitalized patients and may reflect systemic vulnerability beyond the local wound condition. Malignancy recorded among secondary diagnoses may identify patients with reduced physiological reserve and increased inpatient risk, but its prognostic significance in hospitalized chronic ulcer populations remains insufficiently characterized. This study aimed to evaluate whether malignancy coded among secondary diagnoses was associated with in-hospital mortality among adults hospitalized with chronic ulcers. Methods: This nationwide retrospective cohort study used anonymized Romanian public-hospital discharge data for adults aged ≥18 years hospitalized with chronic ulcers between 1 January 2017 and 31 December 2022. The index-episode cohort included 69,349 patients generating 116,264 hospitalizations. Exposure was defined as at least one ICD-10 C00-C97 malignant neoplasm code recorded among secondary diagnoses in the relevant analytical hospitalization. The primary outcome was in-hospital mortality. Crude and adjusted odds ratios were estimated using logistic regression models. Results: Overall, 1837 patients had C00-C97 codes recorded among secondary diagnoses, with 73 deaths. In-hospital mortality was 3.97% among exposed patients and 1.78% among unexposed patients, corresponding to a crude odds ratio of 2.28 (95% CI 1.79-2.90). After adjustment for age group, sex, admission type, chronic ulcer category, and hospitalization pattern, malignancy recorded among secondary diagnoses remained associated with mortality (adjusted OR 1.87, 95% CI 1.42-2.45; p < 0.001). Additional adjustment for the number of non-malignant secondary diagnoses yielded similar results (adjusted OR 1.88, 95% CI 1.42-2.47; p < 0.001). Conclusions: Malignancy coded among secondary diagnoses may serve as a pragmatic administrative marker of increased in-hospital mortality risk among patients hospitalized with chronic ulcers. However, residual confounding and the absence of cancer-stage information limit causal interpretation.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...